0Studies tracked
0Claims cite
0Videos use
Average study score: 85/100
Bibliography
Studies by this author
1 study attributed to Val Gebski on the platform. Click a card to read the full analysis.
Study
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome
The PREVANZ study tested whether daily oral vitamin D3 supplementation delays conversion to clinically definite multiple sclerosis in adults with high-risk clinically isolated syndrome and whether effects are dose-dependent and safe.